Clinical Trial Update: Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating high-dose disulfiram plus vorinostat as a latency reversal strategy in HIV-infected individuals on ART has been terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Disulfiram (Disulfiram)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Melbourne | Conditions: HIV Infections | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-02-09